Literature DB >> 25281903

Pseudogene CYP4Z2P 3'UTR promotes angiogenesis in breast cancer.

Lufeng Zheng1, Xiaoman Li1, Yi Gu1, Yihua Ma1, Tao Xi2.   

Abstract

Pseudogenes have long been marked as "false" genes, which are similar with real genes but have no apparent function. The 3'UTR is well-known to regulate gene expression post-transcriptionally. Our recent evidence, however, indicates novel functional roles of pseudogene CYP4Z2P 3'UTR (Z2P-UTR). We found that ectopic expression of Z2P-UTR in breast cancer cells significantly increased the expression of VEGF-A without affecting cell proliferation in vitro. Meanwhile, conditioned medium (CM) from Z2P-UTR overexpression cells enhanced proliferation, migration and tube formation of HUVEC, and promoted angiogenesis in ex vivo models. Also, CM increased the expression of VEGFR2 in HUVEC. Our data suggest that Z2P-UTR can promote breast cancer angiogenesis partly via paracrine pathway of VEGF-A/VEGFR2.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3′UTR; Angiogenesis; Breast cancer; CYP4Z2P; VEGF-A

Mesh:

Substances:

Year:  2014        PMID: 25281903     DOI: 10.1016/j.bbrc.2014.09.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Int Rev Cell Mol Biol       Date:  2017-04-21       Impact factor: 6.813

Review 2.  Pseudogene-expressed RNAs: a new frontier in cancers.

Authors:  Xuefei Shi; Fengqi Nie; Zhaoxia Wang; Ming Sun
Journal:  Tumour Biol       Date:  2015-12-10

3.  LncRNA B4GALT1-AS1 recruits HuR to promote osteosarcoma cells stemness and migration via enhancing YAP transcriptional activity.

Authors:  Zhikun Li; Yi Wang; Ruixi Hu; Ruijun Xu; Wei Xu
Journal:  Cell Prolif       Date:  2018-09-04       Impact factor: 6.831

4.  Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA.

Authors:  Yanpeng Ding; Nuomin Liu; Mengge Chen; Yulian Xu; Sha Fang; Wenbin Xiang; Xinying Hua; Gaili Chen; Yahua Zhong; Haijun Yu
Journal:  World J Surg Oncol       Date:  2021-04-22       Impact factor: 2.754

5.  STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer.

Authors:  Xiaoman Li; Lufeng Zheng; Feng Zhang; Jinhang Hu; Jinjiang Chou; Yu Liu; Yingying Xing; Tao Xi
Journal:  Oncotarget       Date:  2016-04-26

6.  RNA-Binding Protein Dnd1 Promotes Breast Cancer Apoptosis by Stabilizing the Bim mRNA in a miR-221 Binding Site.

Authors:  Feng Cheng; Ying Pan; Yi-Min Lu; Lei Zhu; Shuzheng Chen
Journal:  Biomed Res Int       Date:  2017-01-16       Impact factor: 3.411

7.  Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.

Authors:  Xiujuan Zhang; Xiaole Song; Yuting Lai; Bijun Zhu; Jiqin Luo; Hongmeng Yu; Yiqun Yu
Journal:  BMC Cancer       Date:  2021-04-30       Impact factor: 4.430

8.  Pre-B cell leukemia transcription factor 3 induces inflammatory responses in human umbilical vein endothelial cells and murine sepsis via acting a competing endogenous RNA for high mobility group box 1 protein.

Authors:  Yunzhong Zhang; Jing Feng; Jizhen Cui; Guozheng Yang; Xianai Zhu
Journal:  Mol Med Rep       Date:  2018-02-15       Impact factor: 2.952

9.  Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.

Authors:  Lufeng Zheng; Qianqian Guo; Chenxi Xiang; Shijia Liu; Yuzhang Jiang; Lanlan Gao; Haiwei Ni; Ting Wang; Qiong Zhao; Hai Liu; Yingying Xing; Yaohui Wang; Xiaoman Li; Tao Xi
Journal:  J Hematol Oncol       Date:  2019-03-04       Impact factor: 17.388

Review 10.  Re-recognition of pseudogenes: From molecular to clinical applications.

Authors:  Xu Chen; Lin Wan; Wei Wang; Wen-Jin Xi; An-Gang Yang; Tao Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.